Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

46 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers.
Larsson T, Nisbeth U, Ljunggren O, Jüppner H, Jonsson KB. Larsson T, et al. Kidney Int. 2003 Dec;64(6):2272-9. doi: 10.1046/j.1523-1755.2003.00328.x. Kidney Int. 2003. PMID: 14633152
GSK-3 inhibition by an orally active small molecule increases bone mass in rats.
Marsell R, Sisask G, Nilsson Y, Sundgren-Andersson AK, Andersson U, Larsson S, Nilsson O, Ljunggren O, Jonsson KB. Marsell R, et al. Bone. 2012 Mar;50(3):619-27. doi: 10.1016/j.bone.2011.11.007. Epub 2011 Nov 25. Bone. 2012. PMID: 22142634
Fibroblast growth factor-23 is associated with parathyroid hormone and renal function in a population-based cohort of elderly men.
Marsell R, Grundberg E, Krajisnik T, Mallmin H, Karlsson M, Mellström D, Orwoll E, Ohlsson C, Jonsson KB, Ljunggren O, Larsson TE. Marsell R, et al. Eur J Endocrinol. 2008 Jan;158(1):125-9. doi: 10.1530/EJE-07-0534. Eur J Endocrinol. 2008. PMID: 18166826
Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells.
Krajisnik T, Björklund P, Marsell R, Ljunggren O, Akerström G, Jonsson KB, Westin G, Larsson TE. Krajisnik T, et al. J Endocrinol. 2007 Oct;195(1):125-31. doi: 10.1677/JOE-07-0267. J Endocrinol. 2007. PMID: 17911404
Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis.
Larsson T, Marsell R, Schipani E, Ohlsson C, Ljunggren O, Tenenhouse HS, Jüppner H, Jonsson KB. Larsson T, et al. Endocrinology. 2004 Jul;145(7):3087-94. doi: 10.1210/en.2003-1768. Epub 2004 Feb 26. Endocrinology. 2004. PMID: 14988389
Preoperative tumor localization by means of venous sampling for fibroblast growth factor-23 in a patient with tumor-induced osteomalacia.
Westerberg PA, Olauson H, Toss G, Wikström B, Morales O, Linde T, Jonsson K, Ljunggren O, Larsson TE. Westerberg PA, et al. Endocr Pract. 2008 Apr;14(3):362-7. doi: 10.4158/EP.14.3.362. Endocr Pract. 2008. PMID: 18463045
The phosphate regulating hormone fibroblast growth factor-23.
Marsell R, Jonsson KB. Marsell R, et al. Acta Physiol (Oxf). 2010 Oct;200(2):97-106. doi: 10.1111/j.1748-1716.2010.02163.x. Acta Physiol (Oxf). 2010. PMID: 20618171 Review.
Relation between fibroblast growth factor-23, body weight and bone mineral density in elderly men.
Marsell R, Mirza MA, Mallmin H, Karlsson M, Mellström D, Orwoll E, Ohlsson C, Jonsson KB, Ljunggren O, Larsson TE. Marsell R, et al. Osteoporos Int. 2009 Jul;20(7):1167-73. doi: 10.1007/s00198-008-0780-2. Epub 2008 Oct 31. Osteoporos Int. 2009. PMID: 18974917 Clinical Trial.
46 results
Jump to page
Feedback